ArticleMethods in molecular biology (Clifton, N.J.)2025
Antibody-Mediated Protein A-APEX2 Labeling (AMAPEX) for Proximity Proteome Exploration.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Siglec-G on B cells restrains the germinal center response by controlling T cell help during positive selection.bioRxiv : the preprint server for biology · 2026Article
- Proximity labeling in neuroscience: decoding molecular landscapes for precision neurology.Translational neurodegeneration · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Exploring protein interactions is essential for understanding cellular biological processes. Traditional methods for studying protein-protein interactions often face limitations in capturing transient or low-affinity interactions due to harsh lysis conditions or antibody specificity challenges. Proximity labeling has emerged as a robust technique that utilizes engineered enzymes to covalently tag proximal proteins, preserving their interactions in vivo. This chapter introduces an advanced method called antibody-mediated protein A-APEX2 labeling (AMAPEX), which enhances the established APEX2 system. AMAPEX utilizes specific antibodies to tether a modified protein to a protein A-APEX2 fusion, enabling targeted biotin labeling of proximal proteins. These labeled proteins are subsequently isolated using streptavidin beads and analyzed by mass spectrometry. Validation of the method is demonstrated by profiling histone modification proxeomes, demonstrating its accuracy in identifying associated cellular components. AMAPEX represents a significant advancement in mapping protein interactions, particularly in the context of posttranslational modifications, making it a valuable tool for biological research and therapeutic development.
Indexed as
Identifiers
40638056What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.